H.R._____/ S._____, Department of Defense Appropriations Act, 2018, Title III, all provisions relating to Navy Shipbuilding (on behalf of Austal).
HR.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to cultural heritage preservation (on behalf of the US Committee of the Blue Shield).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to blood products, Title VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R.___/S.___, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018 (on behalf of Cerus).
H.R___/S/___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018, Title II, all provisions relating to blood products (on behalf of Cerus).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to high performance computing (on behalf of Cray).
H.R.___/S.___, Energy and Water Development Act, 2018, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray).
H.R.___/S.___, Commerce, Justice, Science and Related Agencies Appropriations Act, 2018, Title I, all provisions relating to oceanic and atmospheric research, system acquisition, and research supercomputing; and to National Science Foundation supercomputing (on behalf of Cray).
H.R.___/ S.___, Department of Defense Appropriations Act, 2018, Title III, all provisions relating to ground combat systems, tactical communications systems, and shipbuilding (on behalf of General Dynamics).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to spacecraft propulsion and microprocessors; and any title, all provisions relating to additive manufacturing quality assurance (on behalf of Moog).
HR.___/S.___, Commerce, Justice, Science and Related Agencies Appropriations Act, 2018, Title I, all provisions relating to unmanned vehicles (on behalf of Saildrone).
HR.___/S.___, Department of Defense Appropriations Act, 2018, Title VI, all provisions relating to lung injury and infection control systems (on behalf of Sanovas).
H.R. ___/ S.___, Department of Homeland Security Appropriations Act, 2018, any title, all provisions relating to EB-5 visas (on behalf of Sanovas).
H.R.___/ S.___Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to assured access to space and space architecture resiliency (on behalf of Stratolaunch).
Contacted members of Congress and Congressional committees to discuss Aduro's advanced research efforts, ongoing clinical trials, and FDA regulatory approval (on behalf of Aduro).
H.R.5293 / S.3000 Department of Defense Appropriations Act, 2017, Title III, all provisions related to military ammunition, and facilities (on behalf of Day and Zimmerman).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to space, and space launch policy (on behalf of Arianespace).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, Title I, all provisions relating to Navy Shipbuilding (on behalf of Austal).
H.R.2810/ S.1519, Title III, all provisions relating to cultural heritage preservation (on behalf of the US Committee of the Blue Shield).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to blood products (on behalf of Cerus).
H.R.2810/ S.1519,, National Defense Authorization Act, Title 31, all provisions relating to supercomputing (on behalf of Cray).
H.R.2810/ S.1519,, National Defense Authorization Act, 2018, Title II, all provisions relating to spacecraft propulsion and microprocessors; and any title, all provisions relating to additive manufacturing quality assurance (on behalf of Moog).
H.R.2810/ S.1519,, National Defense Authorization Act, 2018, Title I, all provisions relating to tactical missiles, electronic warfare systems aircraft missiles, surface ship, Army command and control systems, and ballistic missile defense radars; and Title II, all
provisions relating to electronic warfare systems, and air defense and ballistic missile defense radars and platforms (on behalf of Raytheon).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to infection control systems (on behalf of Sanovas).
HR.___/S.___, EB-5 Visa Reauthorization, any title, all provisions relating to EB-5 visa reauthorization (on behalf of Sanovas)
Duration: July 24, 2015
to
May 31, 2017
General Issues: Budget/Appropriations , Government Issues , Defense , Immigration
Spending: about $130,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives, Army - Dept of (Other), Navy - Dept of, Vice President of the U.S., Health & Human Services - Dept of (HHS), State - Dept of (DOS), U.S. Agency for International Development (USAID), Office of the Secretary of Defense
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Neely Silbey
Legislative Assistant, SEN Patty Murray (D-WA)
Legislative Assistant, Office of SEN Patty Murray (WA)
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2017
NMS Strategies terminated an engagement in which they represented Innovative Federal Strategies on July 20, 2017.
Original Filing: 300893888.xml
Lobbying Issues
H.R._____/ S._____, Department of Defense Appropriations Act, 2018, Title III, all provisions relating to Navy Shipbuilding (on behalf of Austal).
HR.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to cultural heritage preservation (on behalf of the US Committee of the Blue Shield).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to blood products, Title VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R.___/S.___, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018 (on behalf of Cerus).
H.R___/S/___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018, Title II, all provisions relating to blood products (on behalf of Cerus).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to high performance computing (on behalf of Cray).
H.R.___/S.___, Energy and Water Development Act, 2018, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray).
H.R.___/S.___, Commerce, Justice, Science and Related Agencies Appropriations Act, 2018, Title I, all provisions relating to oceanic and atmospheric research, system acquisition, and research supercomputing; and to National Science Foundation supercomputing (on behalf of Cray).
H.R.___/ S.___, Department of Defense Appropriations Act, 2018, Title III, all provisions relating to ground combat systems, tactical communications systems, and shipbuilding (on behalf of General Dynamics).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to spacecraft propulsion and microprocessors; and any title, all provisions relating to additive manufacturing quality assurance (on behalf of Moog).
HR.___/S.___, Commerce, Justice, Science and Related Agencies Appropriations Act, 2018, Title I, all provisions relating to unmanned vehicles (on behalf of Saildrone).
HR.___/S.___, Department of Defense Appropriations Act, 2018, Title VI, all provisions relating to lung injury and infection control systems (on behalf of Sanovas).
H.R. ___/ S.___, Department of Homeland Security Appropriations Act, 2018, any title, all provisions relating to EB-5 visas (on behalf of Sanovas).
H.R.___/ S.___Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to assured access to space and space architecture resiliency (on behalf of Stratolaunch).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Contacted members of Congress and Congressional committees to discuss Aduro's advanced research efforts, ongoing clinical trials, and FDA regulatory approval (on behalf of Aduro).
H.R.5293 / S.3000 Department of Defense Appropriations Act, 2017, Title III, all provisions related to military ammunition, and facilities (on behalf of Day and Zimmerman).
Agencies Lobbied
U.S. Senate Army - Dept of (Other)
Lobbying Issues
H.R.2810/ S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to space, and space launch policy (on behalf of Arianespace).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, Title I, all provisions relating to Navy Shipbuilding (on behalf of Austal).
H.R.2810/ S.1519, Title III, all provisions relating to cultural heritage preservation (on behalf of the US Committee of the Blue Shield).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to blood products (on behalf of Cerus).
H.R.2810/ S.1519,, National Defense Authorization Act, Title 31, all provisions relating to supercomputing (on behalf of Cray).
H.R.2810/ S.1519,, National Defense Authorization Act, 2018, Title II, all provisions relating to spacecraft propulsion and microprocessors; and any title, all provisions relating to additive manufacturing quality assurance (on behalf of Moog).
H.R.2810/ S.1519,, National Defense Authorization Act, 2018, Title I, all provisions relating to tactical missiles, electronic warfare systems aircraft missiles, surface ship, Army command and control systems, and ballistic missile defense radars; and Title II, all
provisions relating to electronic warfare systems, and air defense and ballistic missile defense radars and platforms (on behalf of Raytheon).
H.R.2810/ S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to infection control systems (on behalf of Sanovas).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR.___/S.___, EB-5 Visa Reauthorization, any title, all provisions relating to EB-5 visa reauthorization (on behalf of Sanovas)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, NMS Strategies lobbied for Innovative Federal Strategies , earning $20,000. The report was filed on April 20, 2017.
Original Filing: 300875887.xml
Lobbying Issues
H.R._____/ S._____, Department of Defense Appropriations Act, 2018, Title III, all provisions relating to Navy Shipbuilding (on behalf of Austal).
HR.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to cultural heritage preservation (on behalf of the US Committee of the Blue Shield).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to blood products, Title VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R.___/S.___, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018 (on behalf of Cerus).
H.R___/S/___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018, Title II, all provisions relating to blood products (on behalf of Cerus).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to high performance computing (on behalf of Cray).
H.R.___/S.___, Energy and Water Development Act, 2018, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray).
H.R.___/S.___, Commerce, Justice, Science and Related Agencies Appropriations Act, 2018, Title I, all provisions relating to oceanic and atmospheric research, system acquisition, and research supercomputing; and to National Science Foundation supercomputing (on behalf of Cray).
H.R.___/ S.___, Department of Defense Appropriations Act, 2018, Title III, all provisions relating to ground combat systems, tactical communications systems, and shipbuilding (on behalf of General Dynamics).
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to spacecraft propulsion and microprocessors; and any title, all provisions relating to additive manufacturing quality assurance (on behalf of Moog).
H.R.___/ S.___, Department of Defense Appropriations Act, 2018, Titles III and IV, all provisions relating to tactical missiles; electronic warfare
systems; aircraft, missiles, surface ship, and ballistic missile defense radars; Army command and control systems, and cybersecurity (on behalf of Raytheon).
HR.___/S.___, Commerce, Justice, Science and Related Agencies Appropriations Act, 2018, Title I, all provisions relating to unmanned vehicles (on behalf of Saildrone).
HR.___/S.___, Department of Defense Appropriations Act, 2018, Title VI, all provisions relating to lung injury and infection control systems (on behalf of Sanovas).
H.R.___/ S.___Department of Defense Appropriations Act, 2018, Title IV, all provisions relating to assured access to space and space architecture resiliency (on behalf of Vulcan).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Contacted members of Congress and Congressional committees to discuss Aduro's advanced research efforts, ongoing clinical trials, and FDA regulatory approval (on behalf of Aduro).
Lobbying Issues
H.R.______/ S.______, National Defense Authorization Act, 2018, Title I, all provisions relating to Navy Shipbuilding (on behalf of Austal).
HR.___/S.___, Title III, all provisions relating to cultural heritage preservation (on behalf of the US Committee of the Blue Shield).
HR.___/S.___, National Defense Authorization Act, 2018, any title, all provisions relating to blood products (on behalf of Cerus).
HR.___/S., National Defense Authorization Act, Title 31, all provisions relating to supercomputing (on behalf of Cray).
H.R.____/ S.____, National Defense Authorization Act, 2018, Title I, all provisions relating to ground combat systems, tactical communications systems, and shipbuilding (on behalf of General Dynamics).
H.R.____/S.____, National Defense Authorization Act, 2018, Title II, all provisions relating to spacecraft propulsion and microprocessors; and any title, all provisions relating to additive manufacturing quality assurance (on behalf of Moog).
H.R.___/ S.___, National Defense Authorization Act, 2018, Title I, all provisions relating to tactical missiles, electronic warfare systems aircraft missiles, surface ship, Army command and control systems, and ballistic missile defense radars; and Title II, all
provisions relating to electronic warfare systems, and air defense and ballistic missile defense radars and platforms (on behalf of Raytheon).
HR.___/S.___ National Defense Authorization Act, 2018, any title, all provisions relating to infection control systems (on behalf of Sanovas).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR.___/S.___, EB-5 Visa Reauthorization, any title, all provisions relating to EB-5 visa reauthorization (on behalf of Sanovas)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, NMS Strategies lobbied for Innovative Federal Strategies , earning $20,000. The report was filed on Jan. 24, 2017.
Original Filing: 300858927.xml
Lobbying Issues
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV and VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, Divisions B, Title V, all provisions relating to supplemental fiscal year 2016 funds to combat the Zika outbreak (on behalf of Cerus).
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to test facilities and microprocessors for spacecraft (on behalf of Moog Inc.).
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to high performance computing (on behalf of Cray).
H.R. 5293/S. 3000, Department of Defense Appropriations Act, 2017, Title III, all provisions relating to military ammunition; and Title IV, all provisions relating to demilitarization, decontamination, air purification systems, and rocket motors (on behalf of Day and Zimmermann).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other)
Lobbying Issues
Contacted Members of Congress on blood safety in blood banks and hospitals, and to provide information on Cerus' contact with BARDA for blood safety.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, NMS Strategies lobbied for Innovative Federal Strategies , earning $10,000. The report was filed on Oct. 20, 2016.
Original Filing: 300837597.xml
Lobbying Issues
H.R.5912/S.3117, Department of State, Foreign Operations, and Related Agencies Appropriations Act, 2017, Title I, all provisions relating to cultural heritage (on behalf of the US Committee of the Blue Shield).
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV and VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, Divisions B, Title V, all provisions relating to supplemental fiscal year 2016 funds to combat the Zika outbreak (on behalf of Cerus).
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to test facilities and microprocessors for spacecraft (on behalf of Moog Inc.).
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to high performance computing (on behalf of Cray).
H.R. 5293/S. 3000, Department of Defense Appropriations Act, 2017, Title III, all provisions relating to military ammunition; and Title IV, all provisions relating to demilitarization, decontamination, air purification systems, and rocket motors (on behalf of Day and Zimmermann).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Navy - Dept of Army - Dept of (Other)
Lobbying Issues
H.R.4909/S.2943, National Defense Authorization Act, 2017, Title I, all provisions relating to tactical missiles, electronic warfare systems, and satellite operational control systems; and aircraft missiles, surface ship, and ballistic missile defense radars; and Title II, all provisions relating to electronic warfare systems, satellite operations control systems, and air defense and ballistic missile defense radars (on behalf of Raytheon).
H.R.4909/S.2943, National Defense Authorization Act, 2017, any title, all provisions relating to cultural heritage (on behalf of the US Committee of the Blue Shield).
S.J. Res. 39, a Resolution of Disapproval on foreign military sales to Saudi Arabia (on behalf of General Dynamics).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Contacted White House Staff to Request a meeting on Moonshot Cancer Initiatives (on behalf of Aduro).
Attended a meeting with an official from the office of the Vice President to discuss Aduro's cancer immunotherapies and possible collaboration with the Vice President's Cancer Task Force and Moonshot Initiative. Contacted Members of Congress to provide the same information( on behalf of Aduro).
Contacted Congressional offices on the status of the Cures Act (on behalf of Aduro).
Agencies Lobbied
Vice President of the U.S.
2nd Quarter, 2016
In Q2, NMS Strategies lobbied for Innovative Federal Strategies , earning $10,000. The report was filed on July 20, 2016.
Original Filing: 300821926.xml
Lobbying Issues
H.R.___/S.___, Department of State, Foreign Operations, and Related Agencies Appropriations Act, 2017, Title I, all provisions relating to cultural heritage (on behalf of the US Committee of the Blue Shield).
H.R.___/S.___, Commerce Justice, Science and Related Agencies Appropriations Act, 2017, Title I, all provisions relating to oceanic and atmospheric research, system acquisition, and research supercomputing; and to National Science Foundation Supercomputing (on behalf of Cray, Inc.).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title IV and VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines (on behalf of Aduro Biotech).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to test facilities and microprocessors for spacecraft (on behalf of Moog Inc.).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Titles III and IV, all provisions relating to tactical missiles; electronic warfare systems; satellite operations control systems; aircraft, missiles, surface ship, ballistic missile defense radars; and cybersecurity (on behalf of Raytheon).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other) Navy - Dept of
Lobbying Issues
H.R.___/S.___, National Defense Authorization Act, 2017, Title I, all provisions relating to tactical missiles, electronic warfare systems, and satellite operational control systems; and aircraft missiles, surface ship, and ballistic missile defense radars; and Title II, all provisions relating to electronic warfare systems, satellite operations control systems, and air defense and ballistic missile defense radars (on behalf of Raytheon).
H.R.___/S.___, National Defense Authorization Act, 2017, any title, all provisions relating to cultural heritage (on behalf of the US Committee of the Blue Shield).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Contacted White House Staff to Request a meeting on Moonshot Cancer Initiatives.
Agencies Lobbied
Vice President of the U.S.
1st Quarter, 2016
In Q1, NMS Strategies lobbied for Innovative Federal Strategies , earning $30,000. The report was filed on April 20, 2016.
Original Filing: 300803670.xml
Lobbying Issues
H.R.___/S.___, Department of State, Foreign Operations, and Related Agencies Appropriations Act, 2017, Title I, all provisions relating to cultural heritage (on behalf of the US Committee of the Blue Shield).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to high performance computing (on behalf of Cray, Inc.).
H.R.___/S.___, Energy and Water Development Act, 2017, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray, Inc.).
H.R.___/S.___, Commerce Justice, Science and Related Agencies Appropriations Act, 2017, Title I, all provisions relating to oceanic and atmospheric research, system acquisition, and research supercomputing; and to National Science Foundation Supercomputing (on behalf of Cray, Inc.).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title IV and VI, all provisions related to blood products and technologies (on behalf of Cerus).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title III, all provisions relating to tactical communication systems (on behalf of General Dynamics Corporation).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines (on behalf of Aduro Biotech).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to test facilities and microprocessors for spacecraft (on behalf of Moog Inc.).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Titles III and IV, all provisions relating to tactical missiles; electronic warfare systems; satellite operations control systems; aircraft, missiles, surface ship, ballistic missile defense radars; and cybersecurity (on behalf of Raytheon).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to assured access to space (on behalf of Vulcan Inc.).
H.R.___/S.___, Department of Defense Appropriations Act, 2017, Title III, all provisions relating to Navy Shipbuilding (on behalf of Austal).
H.R.___/S.___, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2016, Title II, all provisions relating to personal property protection systems (on behalf of Rejjee).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other)
Lobbying Issues
H.R.___/S.___, National Defense Authorization Act, 2017, Title I, all provisions relating to Navy Shipbuilding (on behalf of Austal).
H.R.___/S.___, National Defense Authorization Act, 2017, Title I, all provisions relating to tactical missiles, electronic warfare systems, and satellite operational control systems; and aircraft missiles, surface ship, and ballistic missile defense radars; and Title II, all provisions relating to electronic warfare systems, satellite operations control systems, and air defense and ballistic missile defense radars (on behalf of Raytheon).
S.___, National Defense Authorization Act, 2017, Title II all provisions relating to test facilities and microprocessors for spacecraft (on behalf of Moog Inc.).
H.R.___/S.___, National Defense Authorization Act, 2017, Title I, all provisions relating to tactical communications systems and Navy Ship Jones Act requirements (on behalf of General Dynamics Corporation).
H.R.___/S.___, National Defense Authorization Act, 2017, any title, all provisions relating to cultural heritage (on behalf of the US Committee of the Blue Shield).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Contacted Army official to discuss global positioning systems (on behalf of Trimble).
Met with Congressional staff on blood safety issues (on behalf of Cerus).
Met with Department of Health and Human Services personnel to discuss blood safety issues (on behalf of Cerus).
Met with U.S. Agency for International Development personnel and Congressional staff to provide information on neglected tropical diseases (on behalf of Aduro Biotech).
Contacted State Department officials to discuss the Hague Second Protocol (on behalf of the US Committee of the Blue Shield).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other) Health & Human Services - Dept of (HHS) State - Dept of (DOS) U.S. Agency for International Development (USAID)
4th Quarter, 2015
In Q4, NMS Strategies lobbied for Innovative Federal Strategies , earning $10,000. The report was filed on Jan. 20, 2016.
Original Filing: 300782337.xml
Lobbying Issues
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles III and IV, all provisions relating to tactical missiles (on behalf of Raytheon).
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Title III, all provisions relating to tactical communications and surveillance systems and ground combat vehicles (on behalf of General Dynamics Corporation).
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Title III, all provisions relating to global positioning systems (on behalf of Trimble).
H. 2028, Energy and Water Development Appropriations Act, 2016, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray, Inc.).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other)
Lobbying Issues
H. 1735 / S. 1356, National Defense Authorization Act for Fiscal Year 2016, Division A, all provisions related to acquisition of IT equipment (on behalf of HPE).
H. 1735 / S. 1356, National Defense Authorization Act for Fiscal Year 2016, Division A, all provisions related to the protection of cultural heritage property (on behalf of the US Committee of the Blue Shield).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of the Secretary of Defense
3rd Quarter, 2015
NMS Strategies amended a lobbying report for representation of Innovative Federal Strategies in Q32015 on Oct. 21, 2015.
Original Filing: 300766002.xml
Lobbying Issues
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles III and IV, all provisions relating to tactical missiles (on behalf of Raytheon).
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Title III, all provisions relating to tactical communications systems and ground combat vehicles (on behalf of General Dynamics Corporation).
H. 2028, Energy and Water Development Appropriations Act, 2016, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray, Inc.).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other)
3rd Quarter, 2015
In Q3, NMS Strategies lobbied for Innovative Federal Strategies , earning $10,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764383.xml
Lobbying Issues
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles III and IV, all provisions relating to tactical missiles (on behalf of Raytheon).
H. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Title III, all provisions relating to tactical communications systems and ground combat vehicles (on behalf of General Dynamics Corporation).
H. 2028, Energy and Water Development Appropriations Act, 2016, Title III, all provisions relating to advanced scientific computing research and advanced simulation and computing (on behalf of Cray, Inc.).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Army - Dept of (Other)
3rd Quarter, 2015
NMS Strategies filed a lobbying registration on July 28, 2015 to represent Innovative Federal Strategies, effective July 24, 2015.
Original Filing: 300747916.xml
Issue(s) they said they’d lobby about: All provisions related to firm's individual client to be detailed on quarterly lobbying disclosure reports. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate